Latest news with #SASS
Straits Times
04-07-2025
- Straits Times
Students spend ‘A Day in Court' to learn more about Singapore's justice system
Sign up now: Get ST's newsletters delivered to your inbox SINGAPORE – Some secondary school students took over the State Courts on July 4, stepping into the shoes of judges, lawyers, witnesses, court officers and interpreters as part of mock trials for a harassment case. It was not all serious. A 'judge' waved playfully from his bench at his classmates in the courtroom, and students cheered as their peers acted out a script based on a harassment case study they had discussed earlier. The role play sessions were part of a 'A Day in Court', an annual programme started in 2014 by the Singapore State Courts to give students insights into Singapore's justice system. As with the previous three years, this year's programme focused on harassment, in the light of harassment and cyber bullying on social media. In her opening address to about 200 Secondary 3 students from 43 schools, Principal District Judge Thian Yee Sze said she hoped they would learn some of the legal remedies that harassment victims may seek, and practical life skills to handle harassment if they or their loved ones face it. Role play sessions, last conducted in 2018, were brought back to give students a more interactive and informal learning experience, the organisers said. New activities included 'CaseGoWhere', a quiz where students are given different cases and determine which court the case will be heard in, and 'You Be the Judge', where students evaluate a mock stalking and cyber bullying case study and decide on the most appropriate ruling. The programme wrapped on a fireside chat where district judges explained what they consider before deciding the outcome of a case. Neoh Wen Xuan, 15, from Hua Yi Secondary School, said she felt inspired to sit in the judge's seat and experience how judges carry out their jobs daily. Her schoolmate Lu Jian Zhi, 15, said: 'I think the court is a very mysterious place because videos and photographs are not allowed inside... (The courtroom) is not something that a lot of people have access to, so I think it was a really eye-opening experience.' Other students said they felt inspired and wanted to apply the lessons they learnt back in school. 'I think we could create a helpline for students facing (harassment) problems, who are afraid to reach out to their friends, close family or trusted adults,' said 15-year-old Puneet Kishore, vice-captain of discipline and development in the lifelong learning programme at St Andrew's Secondary School (SASS). 'Or, we could create a support system for people who call the helpline by having people check in on them regularly, befriend them, or sit with them during lunch,' he added. SASS captain Linus Louie Yim Kwan, 15, said he would share what was learnt about the legal system to prosecute harassment with his peers, to help them understand the implications of their actions if they harass others. Ms Ratna Mitra IIIyas, 28, student leadership teacher at SASS, said: 'We always try to educate our students about legal issues as young as possible, so that they grow up to be more socially aware.' Programmes like 'A Day in Court' give students exposure to topics that schools cannot cover in depth, she added.
IOL News
26-06-2025
- Politics
- IOL News
Outrage and alarm at revelations of sexual, physical and emotional abuse
SASS calls on the Commission for the Promotion & Protection of the Rights of Cultural, Religious & Linguistic Communities (the CRL Rights Commission) to hold an enquiry into the activities of this church, amid the allegations of harm perpetrated on young South African victims. The South African Secular Society (SASS) expresses its outrage and alarm at revelations of sexual, physical and emotional abuse perpetrated by members of yet another religious organisation. A recent online article has brought to light the abuse of an appalling number of members of a secretive Christian 'church' named the Two-by-Twos. Most of the victims are children, and the abuse has been going on in the USA, Canada, New Zealand, South Africa, and elsewhere for decades. SASS calls on the Commission for the Promotion & Protection of the Rights of Cultural, Religious & Linguistic Communities (the CRL Rights Commission) to hold an enquiry into the activities of this church, amid the allegations of harm perpetrated on young South African victims. SASS points out that the South African Bill of Rights protects all citizens who wish to join religious organisations to practice their religion. However, the Constitution also protects the human dignity and security of the person of all who live in South Africa. Section 28 of the Bill of Rights specifically states that children must be protected from maltreatment and abuse. Furthermore, the Children's Act, 2005, states: Every child has the right not to be subjected to social, cultural and religious practices which are detrimental to his or her well-being. The Commission was established to protect and promote the rights of cultural, religious and linguistic communities. However, the Commission also acknowledges its responsibilities in protecting the rights of members of cultural and religious communities. Commissioners work with key stakeholders as well as affected families to address the various religious and cultural issues, for example, the well-being of young initiates in initiation practices and the management of the practice of ukuhlolwa / virginity testing. It was also the body that addressed the needs of the victims of Kwa Sizabantu Mission, and has expressed support for victims of abuse in high-profile cases such as that of Pastor Timothy Omotoso. Indeed, the Commission is working to establish and approve a Peer Review Council intended to address the conduct of some religious leaders who continue to abuse their followers. The SA Secular Society believes that an inquiry into the affairs and activities of this secretive and abusive sect falls directly under the remit of the Commission, and it urges the Commission to investigate the Two by Two Church as soon as possible. Vanessa Bower, vice president of the SA Secular Society
United News of India
20-05-2025
- United News of India
Electric shock from water tap, woman Ayyappa devotee from Telangana dies at Pamba
Sabarimala, May 20 (UNI) In a shocking incident, a 60-year-old woman Ayyappa devotee was electrocuted to death while trying to open a drinking water tap at Pamba, leading to protest by Sabarimala Ayyappa Seva Samajam (SASS) demanding a probe into the incident and compensation for the victim from Telangana. SASS National Chairman SJR Kumar has strongly condemned the incident and demanded an immediate and thorough probe into the cause of the tragic loss of life. "The unfortunate incident occurred when she attempted to open the drinking water tap in shed number two while returning after Darshan at the Lord Ayyappa temple in Sabarimala on Monday evening. Despite being rushed to Pampa Hospital, her life could not be saved." "It is unlikely that a normal 220V supply would result in such a sudden death, raising serious concerns about a potential surge in the electric supply. This needs to be investigated urgently," he said. The SASS also calls for an inquiry into whether immediate and timely first aid and medical assistance were provided, which could have potentially averted this tragic outcome. The victim was identified as E. Bharathamma, a resident of Gopalpet Mandal, Mahabubnagar, Telangana. Considering the financially vulnerable background of the deceased, whose husband passed away 25 years ago, leaving behind a son and a daughter dependent on her, the Sabarimala Ayyappa Seva Samajam demands that the bereaved family be provided with suitable compensation. The Samajam also urged the concerned authorities to take immediate and necessary steps to prevent any such occurrences and negligence in Sabarimala in the future, ensuring the safety and well-being of all pilgrims. He also demanded a probe by a team of expert engineers from the Kerala Electrical Inspectorate to determine whether the Travancore Devaswom Board or the Kerala State Electricity Board (KSEB) is responsible for the electrical installations at the site. He also condoled the tragic death of the devotee and conveyed his deep sympathies to her grieving family. UNI DS BD
Yahoo
08-04-2025
- Business
- Yahoo
Apnimed doses first subject in trial for sleep apnoea with central component
US-based Apnimed has dosed the first subject in the multi-centre Phase IIA RESTEADY trial of SASS-001, an oral drug combo for sleep apnoea with a central component. SASS-001 is a combination of selective P2X3 receptor antagonist, sivopixant, and another compound. The randomised, controlled, dose-escalation, double-blind, parallel-arm trial is intended for underserved individuals with this condition. It aims to enrol about 60 subjects at up to ten clinical sites in the US. Subjects are set to be randomised to a dose-escalating arm of the therapy or a placebo arm. They will take part in the trial for a ten-week period, with study measures including sleep-clinic polysomnography as well as at-home sleep assessments. SASS-001 comes from Apnimed's joint venture (JV) with Shionogi, named Shionogi-Apnimed Sleep Science (SASS), as its first clinical-stage asset. The JV aims at expediting the discovery, preclinical and clinical development of pharmacologic solutions for addressing the pathology of sleep apnoea and other sleep-related conditions. Apnimed CEO Larry Miller said: 'With the first patient dosed in the Phase IIA RESTEADY trial, both Apnimed and SASS have reached an important milestone – the advancement of a scientific hypothesis to clinical development. 'Today's announcement represents the combined efforts of the Apnimed and Shionogi teams, highlighting their respective strengths in sleep medicine drug development and drug discovery.' In parallel, AD109, the company's clinical programme, is advancing after the enrolment conclusion in its Phase III trials, LunAIRo and SynAIRgy, with these trials' top-line data expected in the second and third quarters of this year, respectively. AD109 is under evaluation in obese and non-obese adults with mild, moderate, and severe obstructive sleep apnoea (OSA). In May 2023, the company reported positive outcomes from the MARIPOSA Phase IIb trial of AD109 for the treatment of OSA. "Apnimed doses first subject in trial for sleep apnoea with central component" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
08-04-2025
- Business
- Yahoo
Apnimed doses first subject in trial for sleep apnoea with central component
US-based Apnimed has dosed the first subject in the multicentre Phase IIA RESTEADY trial of SASS-001, an oral drug combo for sleep apnoea with a central component. SASS-001 is a combination of selective P2X3 receptor antagonist, sivopixant, and another compound. The randomised, controlled, dose-escalation, double-blind, parallel-arm trial is intended for underserved individuals with this condition. It aims to enrol about 60 subjects at up to ten clinical sites in the US. Subjects are set to be randomised to a dose-escalating arm of the therapy or a placebo arm. They will take part in the trial for a ten-week period, with study measures including sleep-clinic polysomnography as well as at-home sleep assessments. SASS-001 comes from Apnimed's joint venture (JV) with Shionogi, named Shionogi-Apnimed Sleep Science (SASS), as its first clinical-stage asset. The JV aims at expediting the discovery, preclinical and clinical development of pharmacologic solutions for addressing the pathology of sleep apnoea and other sleep-related conditions. Apnimed CEO Larry Miller said: 'With the first patient dosed in the Phase IIA RESTEADY trial, both Apnimed and SASS have reached an important milestone – the advancement of a scientific hypothesis to clinical development. 'Today's announcement represents the combined efforts of the Apnimed and Shionogi teams, highlighting their respective strengths in sleep medicine drug development and drug discovery.' In parallel, AD109, the company's clinical programme, is advancing after the enrolment conclusion in its Phase III trials, LunAIRo and SynAIRgy, with these trials' top-line data expected in the second and third quarters of this year, respectively. AD109 is under evaluation in obese and non-obese adults with mild, moderate, and severe obstructive sleep apnoea (OSA). In May 2023, the company reported positive outcomes from the MARIPOSA Phase IIb trial of AD109 for the treatment of OSA. "Apnimed doses first subject in trial for sleep apnoea with central component" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
